Communiqués NutraLife BioSciences, Inc.

Actions

NLBS

US67098B1070

Temps Différé OTC Markets Autres places de cotation 20:02:07 27/06/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-99,00 %		-.--%	-99,50 %

2022	NutraLife BioSciences, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2022	CI
2022	NutraLife Biosciences, Inc. signe un accord de distribution principal avec Whole Foods Full Spectrum Processing	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update and Announces the Acquisition of Healthcare Concierges USA	01/03/23	AQ
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	28/02/23	AQ
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21/11/22	AQ
NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update	17/11/22	AQ
NutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution Agreement	27/10/22	AQ
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	12/10/22	AQ
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22/08/22	AQ
NUTRALIFE BIOSCIENCES, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17/08/22	AQ
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	08/07/22	AQ
NutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional Investors	15/06/22	AQ
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23/05/22	AQ
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	11/04/22	AQ
NutraLife Biosciences Signs Partnership Agreement with CRP & Prepares for OTCQB Uplisting	07/02/22	GL
NutraLife Biosciences Signs Partnership Agreement with Cookies Licensed Retail Products & Prepares for OTCQB Uplisting	01/02/22	AQ
NutraLife Biosciences, inc. to Webcast Live at VirtualInvestorConferences.com February 3rd	27/01/22	AQ
NutraLife Accelerates Expansion Into the Rapidly Growing $11 Billion CBD Industry	10/01/22	AQ
NutraLife Biosciences Partners with KOR Medical to Create Cannabinoid-Based Wellness Products	17/12/21	GL
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	15/11/21	AQ
NUTRALIFE BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	16/08/21	AQ
NutraLife Biosciences Inc. (NLBS) Announces the Company's Financial Fully Reporting Status	05/08/21	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués NutraLife BioSciences, Inc.

Actions

NLBS

US67098B1070

Communiqués

Filtres